| Financial Year |
March 31 2023 |
| Monetary Funds |
825,848,914.57 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
494,299,548.80 |
| Advances to Suppliers |
31,891,378.97 |
| Other Receivables |
16,101,437.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
958,219.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,432,341.44 |
| Total Current Assets |
1,371,531,841.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
892,430,282.89 |
| Investment Properties |
-- |
| Fixed Assetes |
21,281,521.76 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,218,965.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,109,440.39 |
| Deferred Income Tax Assets |
7,177,996.55 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,167,128,775.39 |
| Total Assets |
2,538,660,616.39 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
82,324,689.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,768,612.44 |
| Taxes Payable |
14,986,971.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
359,067,606.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
245,051,871.65 |
| Other Current Liabilities |
131,653.15 |
| Sub-Total of Current Liabilities |
705,748,194.58 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
305,422,868.48 |
| Deferred Income Tax Liabilities |
16,763.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
373,688,108.15 |
| Total Liabilities |
1,079,436,302.73 |
| Paid-In Capital(Or Share Stock) |
516,065,720.00 |
| Capital Surplus |
1,101,271,901.64 |
| Surplus Reserve |
17,804,083.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-160,377,271.67 |
| Minority Stockholder's Interest |
-12,479,094.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,471,703,408.17 |
| Owner's Equity（Stockholder's Equity） |
1,459,224,313.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,538,660,616.39 |
